Aflibercept as a Treatment for Secondary Central Serous Chorioretinopathy in a Patient With Myasthenia Gravis

We report on a case of central serous chorioretinopathy (CSCR) secondary to chronic steroid use that showed sustained improvement when treated with an aflibercept intravitreal injection. A 44-year-old woman presented with decreased visual acuity of the left eye (OS). The patient had a recent history...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez Marquez, Estefania, Requejo Figueroa, Guillermo A, Pappaterra-Rodriguez, Mariella, Ayala Rodríguez, Sofía C, Puebla, Guillermo, Nieves, Ileana, Oliver, Armando L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733583/
https://www.ncbi.nlm.nih.gov/pubmed/36514621
http://dx.doi.org/10.7759/cureus.31287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733583/
https://www.ncbi.nlm.nih.gov/pubmed/36514621
http://dx.doi.org/10.7759/cureus.31287

Ejemplares similares